Skip to main content

Table 2 Clinical Characteristics of NAFLD+CHD Patients and NAFLD Patients

From: TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population

Parameters NAFLD+CHD (n = 156) NAFLD (n = 146) Statistics P value
Male/Female 76/80 81/65 χ2 = 0.421 0.516
Age, y 64.00 (59.00, 72.75) 64.00 (45.00, 74.00) Z = − 0.644 0.520
BMI, kg/m2 25.47 (23.05, 27.68) 26.35 (24.86, 28.49) Z = −3.431 0.001
ALT, U/L 23.58 (16.07, 34.36) 22.67 (18.30, 35.68) Z = − 0.919 0.358
AST, U/L 21.29 (16.80, 32.02) 21.55 (18.38, 28.09) Z = − 0.647 0.517
GGT, U/L 30.70 (21.31, 42.67) 32.55 (20.97, 47.79) Z = − 0.986 0.324
ALP, U/L 79.52 (66.58, 96.46) 68.48 (59.09, 81.81) Z = −3.124 0.002
TG, mmol/L 1.58 (1.13, 2.18) 1.54 (1.16, 2.21) Z = −0.145 0.885
TC, mmol/L 4.64 (3.75, 5.54) 5.42 (4.98, 6.02) Z = −1.682 0.093
HDL, mmol/L 1.02 (0.88, 1.12) 1.19 (1.05, 1.32) Z = −6.741 < 0.001
LDL, mmol/L 2.86 (2.10, 3.45) 3.30 (2.97, 3.52) Z = − 1.332 0.183
TBIL, μmol/L 12.70 (9.70, 16.77) 12.00 (10.00, 14.90) Z = − 0.842 0.040
FPG, mmol/L 5.70 (4.68, 6.96) 4.96 (4.52, 5.79) Z = −3.503 < 0.001
  1. Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; FPG, fasting plasma glucose; GGT, γ-glutamyltransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TBIL, total bilirubin; TC, total cholesterol; TG, triglyceride